November 7, 2014

Perrigo may one day expand into the branded side of the U.S. OTC business, Joseph Papa, Perrigo president, chairman and CEO, told analysts Thursday morning.

November 7, 2014

Teva Pharmaceutical on Friday announced positive findings from a Phase III clinical study that examined the safety and efficacy of Qnasl.

November 6, 2014

A Belgian healthcare website recently presented the lighter side of researching medical conditions on Google. 

November 5, 2014

Novo Nordisk on Wednesday announced the relaunch of Cornerstones4Care, an online patient support platform for people living with diabetes.

November 5, 2014

Excellus BlueCross BlueShield patients can now have prescriptions filled at Wegmans, with free home delivery.

 

November 4, 2014

Across the front-end, CVS Health is in the midst of enhancing its digital capabilities. That , along with insight into the impact of its exit from the tobacco business, was the message Tuesday morning during the company's third-quarter conference call.

November 4, 2014

The newly updated Immunizations app allows users to find pharmacies and clinics that provide free or low-cost immunizations. 

November 4, 2014

The Iowa Board of Pharmacy is revisiting advocating the medical use of marijuana to state legislators.

November 4, 2014

MediSafe expanded its medication management platform to offer users a contextual personalized medication experience through a feed based on users’ medications.

November 3, 2014

A potentially breathable, respiratory vaccine in development has been shown to provide long-term protection for nonhuman primates against the Ebola virus.

 

November 3, 2014

Protein Sciences Corp. last week announced that the Food and Drug Administration approved Flublok influenza vaccine for all adults ages 18 years and older.

November 3, 2014

Research shows that 140 million American adults (about 65%) are recommended for behavioral weight-loss treatment, with 83% of those (or 116 million) considered for pharmacotherapy, according to a report released by The Obesity Society on Monday.

November 3, 2014

“Mild” control of systolic pressure is adequate for adults age 65 or older. 

October 31, 2014

As many as 62% of attendees at the Academy of Integrative Health & Medicine annual conference this week said that the most important factor in stopping Ebola in the United States is controlling the virus and caring for afflicted patients in West Africa.

October 30, 2014

The affiliated companies of Community Care of North Carolina, along with GlaxoSmithKline and the UNC Eshelman School of Pharmacy, on Thursday announced their intent to develop, implement and test new approaches to care delivery. 

October 30, 2014

AstraZeneca on Thursday announced that the Food and Drug Administration approved Xigduo XR (dapagliflozin and metformin hydrochloride extended-release), a once-daily drug for the treatment of adults with Type 2 diabetes. 

October 30, 2014

Sandoz, through its branded dermatology business PharmaDerm, and Medigene AG on Thursday announced a promotion agreement with Women's Choice Pharmaceuticals for Veregen (sinecatechins) ointment, 15% strength. 

October 28, 2014

Novartis announced that it has entered into a definitive agreement to divest its influenza vaccines business to CSL for an agreed price of $275 million.

 

October 27, 2014

Rx Response moved to alert status in response to the concern about Ebola in the United States.

October 24, 2014

Pfizer on Thursday announced that the U.S. District Court for the District of Delaware upheld its basic patent and the L-malate salt patent covering Sutent (sunitinib malate) capsules.

October 23, 2014

Actavis on Thursday confirmed that the United States Court of Appeals for the Federal Circuit has upheld a lower court ruling that found United States Patent No. 7,704,984 (the '984 Patent) to be valid.

October 23, 2014

GlaxoSmithKline expects to have its Ebola vaccine available by year's end.

October 23, 2014

The U.S. healthcare system must address the problem of patients not picking up newly-prescribed medicines, according to a NEHI white paper.

October 23, 2014

The Pharmaceutical Research and Manufacturers of America earlier this week announced that Christina Stow will join the organization as VP communications, effective Oct. 27.